Healthcare
Tuesday, January 17, 2017
BRIEF-Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine
* Agenus Inc says collaboration with National Cancer
Institute to evaluate combination of Pembrolizumab with prophage
autologous vaccine
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment